Biopharmaceutical Development Program (BDP)
Description:
BDP produces a variety of biopharmaceuticals for Phase I/II human clinical trials or advanced preclinical animal testing. Production services include:
- Clinical-grade biological agents from bacterial, yeast, and mammalian cells
- Natural products from various organisms
- Optimization of expression of recombinant proteins
Web Site:
http://web.ncifcrf.gov/research/brb/
Contact:
Dr. George Mitra; mitra@ncifcrf.gov
This page last updated 2007-07-20 14:24:24